Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 427

1.

Glycolipid studies in small intestine and pancreas of alpha1,3-galactosyltransferase knockout miniature swine: alpha1,3GALT-KO animals lack alphaGAL antigens and contain novel blood group H compounds.

Diswall M, Angström J, Schuurman HJ, Dor FJ, Rydberg L, Breimer ME.

Transplant Proc. 2008 Mar;40(2):543-6. doi: 10.1016/j.transproceed.2008.01.032.

PMID:
18374124
2.

Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine.

Diswall M, Angström J, Schuurman HJ, Dor FJ, Rydberg L, Breimer ME.

Transplantation. 2007 Nov 27;84(10):1348-56.

PMID:
18049121
3.

Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies.

Diswall M, Angström J, Karlsson H, Phelps CJ, Ayares D, Teneberg S, Breimer ME.

Xenotransplantation. 2010 Jan-Feb;17(1):48-60. doi: 10.1111/j.1399-3089.2009.00564.x.

PMID:
20149188
4.

The alpha1,3GalT knockout/alpha1,2FucT transgenic pig does not appear to have an advantage over the alpha1,3GalT knockout pig with respect to glycolipid reactivity with human serum antibodies.

Diswall M, Benktander J, Ångström J, Teneberg S, Breimer ME.

Xenotransplantation. 2014 Jan-Feb;21(1):57-71. doi: 10.1111/xen.12071. Epub 2013 Nov 13.

PMID:
24219248
5.

Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists.

Wong BS, Yamada K, Okumi M, Weiner J, O'Malley PE, Tseng YL, Dor FJ, Cooper DK, Saidman SL, Griesemer A, Sachs DH.

Transplantation. 2006 Aug 15;82(3):314-9.

PMID:
16906027
6.

Immune responses to alpha1,3 galactosyltransferase knockout pigs.

Puga Yung G, Schneider MK, Seebach JD.

Curr Opin Organ Transplant. 2009 Apr;14(2):154-60. doi: 10.1097/MOT.0b013e328329250d. Review.

PMID:
19300259
7.

Elicited antibodies in baboons exposed to tissues from alpha1,3-galactosyltransferase gene-knockout pigs.

Tseng YL, Moran K, Dor FJ, Sanderson TM, Li W, Lancos CJ, Schuurman HJ, Sachs DH, Cooper DK.

Transplantation. 2006 Apr 15;81(7):1058-62.

PMID:
16612284
8.

Xenotransplantation and ABO incompatible transplantation: the similarities they share.

Galili U.

Transfus Apher Sci. 2006 Aug;35(1):45-58. Epub 2006 Aug 14. Review.

PMID:
16905361
9.

Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.

Shinkel TA, Chen CG, Salvaris E, Henion TR, Barlow H, Galili U, Pearse MJ, d'Apice AJ.

Transplantation. 1997 Jul 27;64(2):197-204.

PMID:
9256173
10.

Antigen-binding specificity of anti-αGal reagents determined by solid-phase glycolipid-binding assays. A complete lack of αGal glycolipid reactivity in α1,3GalT-KO pig small intestine.

Diswall M, Gustafsson A, Holgersson J, Sandrin MS, Breimer ME.

Xenotransplantation. 2011 Jan-Feb;18(1):28-39. doi: 10.1111/j.1399-3089.2011.00623.x.

PMID:
21342285
11.

Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.

Breimer ME.

Xenotransplantation. 2011 Jul-Aug;18(4):215-28. doi: 10.1111/j.1399-3089.2011.00644.x. Review.

PMID:
21848538
12.

Anti-Gal antibodies in humans and 1, 3alpha-galactosyltransferase knock-out mice.

Chiang TR, Fanget L, Gregory R, Tang Y, Ardiet DL, Gao L, Meschter C, Kozikowski AP, Buelow R, Vuist WM.

Transplantation. 2000 Jun 27;69(12):2593-600.

PMID:
10910282
13.

Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection.

Pearse MJ, Witort E, Mottram P, Han W, Murray-Segal L, Romanella M, Salvaris E, Shinkel TA, Goodman DJ, d'Apice AJ.

Transplantation. 1998 Sep 27;66(6):748-54.

PMID:
9771838
14.

Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs.

Puga Yung GL, Li Y, Borsig L, Millard AL, Karpova MB, Zhou D, Seebach JD.

Xenotransplantation. 2012 May-Jun;19(3):196-206. doi: 10.1111/j.1399-3089.2012.00705.x.

15.

Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.

Posekany KJ, Pittman HK, Swanson MS, Haisch CE, Verbanac KM.

Anticancer Res. 2004 Mar-Apr;24(2B):605-12.

16.

Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons.

Tseng YL, Dor FJ, Kuwaki K, Ryan D, Wood J, Denaro M, Giovino M, Yamada K, Hawley R, Patience C, Schuurman HJ, Awwad M, Sachs DH, Cooper DK.

Xenotransplantation. 2004 Jul;11(4):361-70.

PMID:
15196131
17.
18.

Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection.

Cowan PJ, Chen CG, Shinkel TA, Fisicaro N, Salvaris E, Aminian A, Romanella M, Pearse MJ, d'Apice AJ.

Transplantation. 1998 Jun 27;65(12):1599-604.

PMID:
9665076
19.

Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies.

Shimizu I, Smith NR, Zhao G, Medof E, Sykes M.

Transplantation. 2006 Jan 15;81(1):95-100.

PMID:
16421483
20.

Hyperacute rejection is attenuated in GalT knockout swine lungs perfused ex vivo with human blood.

Schroeder C, Allan JS, Nguyen BN, Wu G, Zhang T, Azimzadeh AM, Madsen JC, Schuurman HJ, Sachs DH, Pierson RN 3rd.

Transplant Proc. 2005 Jan-Feb;37(1):512-3.

PMID:
15808693

Supplemental Content

Support Center